Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies

The field of immuno-oncology has grown exponentially, leading to a host of new therapeutics being developed to recruit the immune system to fight cancer. While T cell-based therapies (BiTES and CARTs) have advanced the farthest, a new wave of drugs that recruit the innate immune system also hold remarkable promise to treat cancer patients with long-term success, but with less side effects.

Panelists will address the opportunities and challenges for these next-generation immuno-oncology drugs which could potentially change the game when it comes to engaging the immune system to kill tumors.